Vivek Jetley built ExlService Holdings' analytics capability and spent nearly 20 years leading the insurance and healthcare businesses at the core of the company's strategy. He departs effective October 26, 2026, to become chief executive officer of Hexaware Technologies Limited. ExlService Holdings (NASDAQ: EXLS) chairman and CEO Rohit Kapoor says the company has a deep bench of talent and will not miss a beat; that assurance is the claim the market now has to price.
Jetley's tenure at EXL covers most of the company's existence. EXL was founded in 1999, and Kapoor described him as "an instrumental part of EXL's evolution" who helped build the analytics function before taking on the Insurance, Healthcare and Life Sciences leadership role. The company, headquartered in New York with approximately 68,000 employees across six continents, describes itself as a global data and AI company. Jetley's division occupies two of the verticals EXL leads with when describing its competitive positioning.
Jetley moves from divisional president to company-wide CEO at Hexaware, a step that offers some indication of how the broader market weighs the executive profile he built at EXL. He will remain in his current role through October 26 and assist with the transfer of his responsibilities in the coming months.
The counterargument to a clean handoff is straightforward: no successor has been named. The 8-K discloses the departure and names no replacement. Kapoor said EXL will not miss a beat executing on its data and AI strategy; Jetley said he looks forward to supporting a smooth transition. EXL's own filing lists leadership recruitment and retention as a stated risk factor, which places both of those statements in the category of projections rather than settled facts.
On balance, the departure of a nearly two-decade division head is the kind of event that reads well in a press release and requires follow-through in execution. The line to watch is who EXL names to lead Insurance, Healthcare and Life Sciences, and when that announcement comes.